Page 123

ENROLLED HB 5001, ENGROSSED 1 2024 LEGISLATURE ______________________________________________________________________________ SECTION 3 - HUMAN SERVICES 456 SPECIAL CATEGORIES GRANTS AND AIDS - HEALTHY START COALITIONS FROM GENERAL REVENUE FUND . . . . . 35,955,341 FROM MATERNAL AND CHILD HEALTH BLOCK GRANT TRUST FUND . . . . . . 4,485,431 From the funds in Specific Appropriation 456, $2,000,000 in nonrecurring funds from the General Revenue Fund is provided for the Nurse Family Partnership Sustainability and Expansion Funding (HF 1059)(SF 2655). 456A SPECIAL CATEGORIES TRANSFER TO BIOMEDICAL RESEARCH TRUST FUND FROM GENERAL REVENUE FUND . . . . . 70,850,000 456B SPECIAL CATEGORIES JAMES AND ESTHER KING BIOMEDICAL RESEARCH PROGRAM FROM BIOMEDICAL RESEARCH TRUST FUND . . . . . . . . . . . . . . . 7,850,000 456C SPECIAL CATEGORIES WILLIAM G. "BILL" BANKHEAD, JR., AND DAVID COLEY CANCER RESEARCH PROGRAM FROM BIOMEDICAL RESEARCH TRUST FUND . . . . . . . . . . . . . . . 10,000,000 From the funds in Specific Appropriation 456C, $500,000 from the Biomedical Research Trust Fund is provided to maintain the statewide Brain Tumor Registry Program at the McKnight Brain Institute (recurring base appropriations project). 457 SPECIAL CATEGORIES HEALTH EDUCATION RISK REDUCTION PROJECT FROM PREVENTIVE HEALTH SERVICES BLOCK GRANT TRUST FUND . . . . . . 12,686 457A SPECIAL CATEGORIES FLORIDA CONSORTIUM OF NATIONAL CANCER INSTITUTE CENTERS PROGRAM FROM GENERAL REVENUE FUND . . . . . 111,071,257 FROM BIOMEDICAL RESEARCH TRUST FUND . . . . . . . . . . . . . . . 16,428,743 Funds in Specific Appropriation 457A are provided for the Casey DeSantis Cancer Research Program established in section 381.915, Florida Statutes. Cancer centers are eligible for Tier 1, Tier 2 and Tier 3 designation to participate in the Casey DeSantis Cancer Research Program as follows: H. Lee Moffitt Cancer Center and Research Institute and Mayo Clinic Comprehensive Cancer Center are eligible for Tier 1 designation as a NCI-designated comprehensive cancer center; the University of Miami Sylvester Comprehensive Cancer Center and the University of Florida Health Shands Cancer Hospital are eligible for Tier 2 designation as a NCI designated cancer centers in the Florida Consortium of NCI Centers Program. All cancer centers receiving funding under the Casey DeSantis Cancer Research Program shall submit to the Florida Cancer Data System, on a quarterly basis beginning September 30, 2024, data on new cancer diagnoses and cancer recurrence. All funded cancer centers shall submit to the Department of Health, on a quarterly basis beginning September 30, 2024, data on patient outcomes by cancer type and mortality and survival rates for patients treated as determined by the Department of Health. By January 1, 2025, all funded cancer centers shall submit a report to the Department of Health containing comprehensive findings and protocols of best practices leading to improved outcomes among patients. A cancer center receiving funds pursuant to the Casey DeSantis Cancer Research Program shall be compliant with the requirements of this proviso, and the Department of Health may recover funds awarded for failure to comply with the requirements of this proviso. 122